These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11385466)

  • 1. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.
    Umaña P; Gerdes CA; Stone D; Davis JR; Ward D; Castro MG; Lowenstein PR
    Nat Biotechnol; 2001 Jun; 19(6):582-5. PubMed ID: 11385466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
    Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
    J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
    Zhou HS; Zhao T; Rao XM; Beaudet AL
    J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
    Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
    Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication and packaging of helper-dependent adenoviral vectors.
    Sato M; Suzuki S; Kubo S; Mitani K
    Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gutless adenoviral vector expressing full-length anti-Her2 antibody.
    Jiang MH; Chen L; Li LF; Wu HP; Jiang LH; Qian YZ; Fang GE; Xue XC
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):e26-31. PubMed ID: 19473346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of various FLP recombinases expressed by adenovirus vectors in mammalian cells.
    Kondo S; Takata Y; Nakano M; Saito I; Kanegae Y
    J Mol Biol; 2009 Jul; 390(2):221-30. PubMed ID: 19414019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gutless adenovirus: last-generation adenovirus for gene therapy.
    Alba R; Bosch A; Chillon M
    Gene Ther; 2005 Oct; 12 Suppl 1():S18-27. PubMed ID: 16231052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.
    Ng P; Evelegh C; Cummings D; Graham FL
    J Virol; 2002 May; 76(9):4181-9. PubMed ID: 11932383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
    Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
    Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of viral vectors using recombinase-mediated cassette exchange.
    Nakano M; Odaka K; Takahashi Y; Ishimura M; Saito I; Kanegae Y
    Nucleic Acids Res; 2005 May; 33(8):e76. PubMed ID: 15879348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential amplification of adenovirus vectors by flanking the packaging signal with attB/attP-PhiC31 sequences: implications for helper-dependent adenovirus production.
    Alba R; Hearing P; Bosch A; Chillon M
    Virology; 2007 Oct; 367(1):51-8. PubMed ID: 17560622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
    Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
    J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
    Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
    Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for the production of helper-dependent adenoviral vectors.
    Palmer DJ; Ng P
    Methods Mol Biol; 2008; 433():33-53. PubMed ID: 18679616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of critical infection parameters to control helper-dependent adenoviral vector production.
    Dormond E; Perrier M; Kamen A
    J Biotechnol; 2009 Jun; 142(2):142-50. PubMed ID: 19501266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficiency between FLPe and Cre for recombinase-mediated cassette exchange in vitro and in adenovirus vector production.
    Takata Y; Kondo S; Goda N; Kanegae Y; Saito I
    Genes Cells; 2011 Jul; 16(7):765-77. PubMed ID: 21707874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.